Clinical Trials Directory

Trials / Completed

CompletedNCT01095952

AV-node Stimulation Clinical Download Study to Reduce Ventricular Rate During AF

Reduction of Ventricular Rate During Atrial Fibrillation by AV Node Stimulation" AVNS Download Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Medtronic BRC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this multi-center research study is to evaluate the performance (primary purpose) and safety of a new algorithm aimed at controlling ventricular rate (VR) during rapidly conducted atrial fibrillation (AF) by delivering AV node stimulation (AVNS) from the atrial lead placed at a septal position, and designed with the purpose of reducing inappropriate shocks. Additional purposes include the assessment of a possible application of AVNS aimed at allowing prolonged control of VR during AF and reducing AF symptoms, and evaluation of implantation data on selective placement of the atrial lead in postero-septal right atrium. About 37 patients will be followed for half a year.

Detailed description

The aim of this multi-center research study is to evaluate the performance (primary purpose) and safety of a new algorithm aimed at controlling VR during rapidly conducted AF by delivering AVNS from the atrial lead placed at a septal position, and designed with the purpose of reducing inappropriate shocks. Additional purposes include the assessment of a possible application of AVNS aimed at allowing prolonged control of VR during AF and reducing AF symptoms, and evaluation of implantation data on selective placement of the atrial lead in postero-septal right atrium. About 37 patients will be followed for half a year.

Conditions

Interventions

TypeNameDescription
DEVICEAVNS ONDelaying the AV-node by stimulating the parasympathetic nerves innervating the AV-node with high frequency burst pacing during the refractory period of the ventricle using a standard atrial lead at a septal position.

Timeline

Start date
2011-11-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2010-03-30
Last updated
2014-02-17

Locations

4 sites across 3 countries: Germany, Italy, Sweden

Source: ClinicalTrials.gov record NCT01095952. Inclusion in this directory is not an endorsement.